Abstract
Pichia pastoris is a popular yeast host for high-level heterologous expression of proteins on an industrial scale owing to its reliable expression, robust growth, high fermentation density, and easy genetic manipulation and cultivation at a relatively low cost. Of particular interest is its high secretion efficiency for small proteins including insulin, human serum albumin, vaccines, enzymes, and llama-derived heavy-chain only antibodies (nanobodies) for pharmaceutical and research applications. However, a recurring challenge in using P. pastoris heterologous secretory proteins is the co-purification of a sticky, yellow pigment which has been identified as a tetra-benzoyl disaccharide. Current methods for pigment removal involve crystallization of the heterologous secretory protein, active carbon absorption, and chromatography using cation exchange and hydrophobic interaction. Here, we present a simple and effective method to remove the yellow pigment, demonstrated with divalent nanobodies targeting SARS-CoV-2. The method entails capturing the nanobody on an affinity column and subsequent washing with the zwitterionic detergent lauryldimethylamine N-oxide (LDAO). We anticipate the method become generally useful to remove pigments from secretion proteins produced in P. pastoris, offering a practical solution to enhance the purity of heterologous proteins in various biotechnological applications.
Highlights
• High-level secretion expression (~250 mg L-1) of divalent nanobodies in Pichia.
• Detergent washing effectively removes yellow pigment from secreted nanobodies.
• Nanobodies after pigment removal remain biologically active.
Similar content being viewed by others
1 Introduction
Pichia pastoris is a robust yeast expression system with many unique advantages (Ahmad et al. 2014; Juturu and Wu 2018). It can grow rapidly on inexpensive medium including defined medium for metabolic labeling (Matthews et al. 2018; Wood and Komives 1999). Available plasmids and kits enable convenient integration of gene-of-interest into the genome, resulting in stable strains with reliable expression (Ahmad et al. 2014); in addition, the multi-site integration and evolving technologies (Marx et al. 2009; Krainer et al. 2012) facilitate ultra-high expression level of both soluble (Sreekrishna et al. 1988; Xiong et al. 2005; Romanos 1995; Cregg et al. 1987) and membrane proteins (Cai et al. 2019; Byrne 2015).
Expression of target proteins can be driven by strong constitutive promoters (Arruda et al. 2016; Xu et al. 2018) or by methanol-inducible promoters in methylotrophic strains (Ahmad et al. 2014; Romanos 1995; Xu et al. 2018; Chang et al. 2018). Conveniently, recombinant proteins may be expressed extracellularly (Lin-Cereghino et al. 2013), bypassing the cell lysis step which is particularly challenging for yeast (Kim et al. 2013), and minimizing contamination from intracellular proteins during purification. Unlike bacterial systems, proteins purified from Pichia lack lipopolysaccharide (endotoxin), a costly impurity that can cause septic shock in humans for intravenous applications (Razdan et al. 2019). In addition, as a eukaryotic organism, P. pastoris is capable of making post-translational modifications such as glycosylation (Ahmad et al. 2014; Higgins 2001; Macauley-Patrick et al. 2005), crucial for the correct folding of some recombinant proteins. Lastly, P. pastoris has a unique advantage in scalable capacity, achieving extremely high cell density (OD600 of 500 or 120-150 g/L of biomass in fermenters) while maintaining expression levels (Cereghino and Cregg 2000). Therefore, P. pastoris has been a popular host for large-scale production of recombinant proteins across pharmaceutical, research, and industrial applications. These proteins include research tool proteins (Files et al. 2001; Nokelainen et al. 2001), digestive enzymes in feed and food industry (Xiong et al. 2005; Guerrero-Olazarán et al. 2010; Zhao et al. 2010; Shu et al. 2015; Cayetano-Cruz et al. 2016; Karim et al. 2019; Minning et al. 1998) such as acid phytase (Xiong et al. 2005), glucoamylase (Karim et al. 2019), lipase (Minning et al. 1998), and vaccines (Cregg et al. 1987; Farnós et al. 2005; Shukla et al. 2017), therapeutic single-chain antibodies (nanobodies) (Spadiut et al. 2014; Roy et al. 2015), and bioactive proteins (Polez et al. 2016; Radulescu et al. 2009; Nagai et al. 2003; Katla et al. 2019; Mallem et al. 2014; Bos et al. 2003; Yu et al. 2018; Rosenfeld et al. 1996) such as insulin (Polez et al. 2016), human interleukin-11 (Yu et al. 2018), and Hirudin (Rosenfeld et al. 1996).
However, a significant challenge arises in the purification of secreted proteins from P. pastoris due to the production of substantial amounts of pigments during methanol induction. These pigments adhere non-specifically and tightly to proteins (Li et al. 2018; Belew et al. 2008; Moore et al. 2010; Steglich et al. 2020; Azadi et al. 2018). A recent study (Moore et al. 2010) has identified the pigment as a benzoylated disaccharide (Glu1-2Xyl-N-Ac) capable of interacting with proteins through electrostatic, hydrophobic and hydrogen-bonding interactions. The removal of these pigments can be variably difficult depending on the nature of the proteins. Existing methods include hydrophobic interaction chromatography and cation exchange chromatography (Moore et al. 2010; Azadi et al. 2018), active carbon (Azadi et al. 2018), and crystallization of the target protein (Moore et al. 2010). Chromatographic methods often involve specialized machines due to the need for gradient solutions in elution, while crystallization technique is target-specific and time-consuming to develop for individual proteins.
Here, we present a simple, efficient, and effective method for pigment removal, using single-chain antibodies (nanobodies) as a case study. The method involves employing the zwitterionic detergent lauryldimethylamine N-oxide (LDAO) to wash off the pigment from the protein immobilized on an affinity column.
2 Material and methods
Yeast nitrogen base without amino acids (YNB, Cat. 233510) was purchased from BD (Sparks, MD, USA). Zeocin (Cat. ant-zn-5b) was from InvivoGen (San Diego, CA, USA). Yeast extract (Cat. LP0021) was from Oxoid (Hampshire, UK). Peptone (Cat. 82962) was obtained from Sigma (St. Louis, MO, USA). SacI restriction enzymes were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Triton X-100 (Cat. X100, Lot. SLBH4329V), N,N-dimethyl-N-dodecylglycine betaine (Empigen) (Cat. 30326), lauryldimethylamine N-oxide (LDAO) (Cat. 40236) were sourced from Sigma. n-dodecyl-β-D-maltopyranoside (DDM, Cat. D310S) was purchased from Anatrace. Other chemicals were sourced from Amresco, Sigma or Sangon Bioteck (Shanghai, China). P. pastoris strains GS115 (his4 Mut+) and SMD1168H (pep4 Mut+) were a kind gift from Professor Rui Bao at Sichuan University, China.
2.1 Expression of sybodies in Pichia pastoris
DNA encoding the sybodies were cloned into the vector pPICZαC (Thermo Fisher Scientific) by Gibson Assembly. The resulting plasmids encode proteins, from the N-terminus to the C-terminus, the α-factor signal sequence, a Gly-Ser linker with sequence GSGSSS, divalent sybodies fused with the albumin binding domain (ABD) (Li et al. 2020; Yao et al. 2020), a Myc tag (EQKLISEEDL), a linker with sequence NSAVD, and a hexa-His tag (Fig. 1A, Table 1). DNA sequences were verified by DNA sequencing. The plasmids were linearized by SacI digestion and transformed into P. pastoris GS115 and SMD1168H competent cells by electroporation in a 0.2-cm cuvette using a Bio-Rad electroporation machine (Gene Pulser Xcell) with the pre-implemented ‘Yeast’ program (Cai et al. 2019). After electroporation, cells were plated on YPDS agar plates (1 %(w/v) yeast extract, 2 %(w/v) peptone, 2 %(w/v) D-glucose, 0.8 M sorbitol, 2 %(w/v) agar) supplemented with 0.5 mg mL-1 zeocin. The plates were incubated at 30 °C for 2 days for colonies to grow. Colonies were first screened for expression in small-scales as follows. Colonies were inoculated into 3 mL of YPD medium (1 %(w/v) yeast extract, 2 %(w/v) peptone, 2 %(w/v) D-glucose) in a 15-mL Falcon tube and cultured overnight at 30 °C in an orbital shaker with shaking at 250 rotation per minute (r.p.m.). Cells were spun down by centrifugation at 3,000 g for 5 min at Room Temperature (RT), washed once with 2 mL BMMY (2 %(w/v) peptone, 1 %(w/v) yeast extract, 1.34 %(w/v) YNB, 400 μg L-1 biotin, 0.5 %(v/v) methanol, 100 mM potassium phosphate pH 5.5) and then re-suspended with 3 mL BMMY to a cell density of OD600 of 3-4. Cells were further grown in a shaker at 20 °C for 48 h to express sybodies. To compare the expression level, equal amounts of cell medium harvested by centrifugation were loaded onto an SDS-PAGE and the protein bands were visualized by Coomassie blue staining.
For large-scale expression, the colony with the highest expression level of sybodies was chosen. The procedure was the same as for the small-scale screening except that the volume at each step was scaled to suit the final protein production in 3-L flasks. In detail, 10-mL overnight cell culture were inoculated into 1-L YPD in a 3-L flask, and cultured overnight at 30 °C in an orbital shaker with shaking at 250 r.p.m.. Cells were spun down by centrifuging at 4,000 g for 10 min at RT, washed with 100 mL BMMY and then resuspended with 100 mL BMMY to increase the OD600 to 100, shake at 20 °C for 4-5 days for induction. For each 24 h, 5 %(v/v) methanol was added to induce the expression. The medium was collected by centrifugation at 5,000 g, filtered through 0.22-μm membrane and the supernatant was used for purification immediately.
2.2 Dialysis
Pichia medium (in 0.35-L batches) was placed in a 14-kDa cut-off dialysis membrane (Cat. D9402, Sigma) for dialysis at 20 °C against 5.5 L of 1 × PBS buffer (1.76 mM KH2PO4, 8.8 mM Na2HPO4, 2.68 mM KCl, 137 mM NaCl) with mild agitation. The dialysis was repeated three times (typically 6-h, 6-h, and 16-h) with a fresh dialysis buffer between each time.
2.3 Ammonium sulfate precipitation
To 0.35-L yeast medium (without dialysis), solid ammonium sulfate (Cat. A501076-0500, Sangon Biotech) was added slowly and with mild agitation to 24.2 %(w/v). The solution was placed at 4 °C for 4 h before centrifugation at 30,000 g for 30 min at 4 °C. The pellet containing the sybodies was re-dissolved in 50 mL of 1 × PBS buffer for further purification.
2.4 Protein A-affinity chromatography
Sybodies from ammonium sulfate precipitation were dialyzed against 4 L of 1 × PBS buffer supplemented with 1 mM EDTA for three times and then remove the insoluble materials at 30,000 g for 30 min at 4 °C. The supernatant was incubated with Protein A resin (Cat. SA012005, Smart-lifesciences) at 4 °C for 1 h. After brief washing (the sybodies only bind to Protein A beads weakly), the sybodies were eluted using 0.1 M glycine pH 3.0 and then immediately neutralize with by adding a tenth volume of 1.5 M NaCl, 1 M Tris HCl pH 8.0.
2.5 Immobilized metal affinity chromatography
Sybodies from the dialyzed medium, or as in the elution of the Protein A beads, were incubated with Ni-NTA beads (Cat. 1018401, Qiagen) for immobilized metal affinity chromatography (IMAC). Typically, 1 mL of Ni-NTA beads for every 0.1 L of culture was used. After 2 h of batch-binding at 4 °C, the beads were placed in a gravity column. The column was washed with 20 column volume (CV) of 20 mM imidazole before eluted with 300 mM imidazole in Buffer A (150 mM NaCl, 20 mM Tris pH 8.0).
2.6 Detergent washing
Sybodies immobilized on the IMAC column were first washed with 20 mM imidazole as described above. Detergents (Triton X-100, DDM, LDAO, Empigen) were individually prepared as 1% solution in Buffer A. The beads were washed with 20 CV of 1% detergents in Buffer A, followed by 30 CV of Buffer A. In the case of LDAO, 0.1 % and 0.5 % of LDAO in Buffer A were additionally tested by washing the resin for 20 CV. Protein was eluted from the beads using 300 mM imidazole in Buffer A.
2.7 Binding assay
Biolayer interferometry (BLI) binding assays were carried out using an Octet RED96 system (FortéBio). Biotinylated RBD (Li et al. 2020) was immobilized on a streptavidin sensor (Cat. 18-5019) by incubating the sensor in 2 μg mL-1 of RBD in the Binding Buffer (0.005 %(v/v) Tween 20, 150 mM NaCl, 20 mM Tris HCl pH 8.0) at 30 °C. The sensor was then equilibrated in the RBD-free Binding Buffer (baseline) for 330 s, before incubating with MR3-MR3-ABD at 10 nM (association) for 300 s. The sensor was then incubated with sybody-free Binding Buffer for dissociation and the BLI signal was monitored for another 300 s. MR3-MR3-ABD expressed in E. coli was purified as previously reported (Li et al. 2020).
2.8 Active carbon treatment
The Pichia medium containing secreted sybodies were incubated with 1%, 2%, 3%, and 5% active carbon in an Eppendorf tube. After incubation at 4 °C for 1.5 h, the mixture was centrifuged at 20,000 g for 20 min at 4 °C. The supernatant fractions at equal volume (10 μL), together with a control sample without treatment, were analyzed by SDS-PAGE and visualized by Coomassie staining.
2.9 Spectroscopy and protein quantification
Absorbance spectroscopy was performed using a Nanodrop machine by applying 2 μL of the sample directly onto the machine. Purified sybodies were quantified using absorbance at 280 nm acquired with a Nanodrop machine and the molar extinction coefficient of 85,510 M-1 cm-1 (MR3-MR3-ABD), 71530 M-1 cm-1 (MR17m-MR17m-ABD), and 68,090 M-1 cm-1 (Sb44-Sb92-ABD).
3 Results and discussion
3.1 High-level expression of sybodies in Pichia pastoris
Previously (Li et al. 2020; Yao et al. 2020; Li et al. 2022 Li et al. 2022), we identified several nanobodies and synthetic nanobodies (sybodies) against the Spike receptor-binding domain (RBD) of SARS-CoV-2, the causative virus of Covid-19. Some of the sybodies bind the RBD at a site that was required for the interaction between RBD and the host cell receptor ACE2, and therefore inhibits the viral infection when tested using pseudoviruses. To test their potency in mice and hamsters, large quantities (dozens of milligrams) were required (Li et al. 2020; Li et al. 2021).
To avoid the problem of endotoxin, we chose the Pichia system for expression. The sybodies were specially engineered as follows. First, they were made divalent by direct fusion with a Gly-Ser linker that contains 34, 20 or 13 amino-acids. Second, the albumin-binding domain (ABD), together with a 15-amino-acids Gly/Ser linker, was fused to the C-terminus of the divalent sybodies for prolonged half-lives in vivo (Li et al. 2020) (Fig. 1A, Table 1). Three sybodies were used in this study. MR3-MR3-ABD (39.2 kDa) and MR17m-MR17m-ABD (38.3 kDa) were neutralizing sybodies. The non-neutralizing sybody (negative control for animal experiments), Sb92-Sb44-ABD (36.7 kDa), was a biparatopic antibody against a thermostable green fluorescence protein (Cai et al. 2020). Because the three sybodies behaved similarly during purification, we’ll universally refer them to as sybody in this study unless specified.
The sybodies were expressed in two P. pastoris strains (GS115 and SMD1168H) with an α-factor secretion signal at the N-terminus (Fig. 1A, Table 1). Therefore, they could be detected conveniently by analyzing the medium on SDS-PAGE. Because the expression level of the target protein in Pichia depends on the position and copy number of target gene integrated into the genome, we first screened colonies for their expression level. As shown in Fig. 1B-G, most colonies showed a band at the expected position of the sybodies on SDS-PAGE and the band was not present in the negative control which are untransformed cells. For MR3-MR3-ABD, one colony, GS115 B3 (panel B, lane 3) did not show expression (Fig. 1B), and SMD1168H C6 showed a band that ran faster than expected (Fig. 1C), suggesting degradation in this colony. Similarly, the Colony E7 for MR17m-MR17m-ABD (Fig. 1E) also showed a band with lower apparent molecular weight than others. In most cases, the samples had a purity of greater than 70%. Based on the expression level, colony #B1 (MR3-MR3-ABD), #D9 (MR17m-MR17m-ABD), and #G7 (Sb92-Sb44-ABD) were selected for large-scale protein production. In a separate study, we quantified the expression level of the MR3-MR3-ABD colony B1 as 250 mg L-1 using SDS PAGE analysis. Specifically, the supernatant of the cell culture was loaded together with known amounts of purified MR3-MR3-ABD which had been pre-mixtured with the medium from the untransformed GS115 cell culture. The band intensity was then semi-quantified by densitometry analysis (Li et al. 2020).
The results indicate that the divalent sybodies can be expressed in Pichia as secreted proteins at a high-level, and highlight the importance to carry out small-scale screening for Pichia expression.
3.2 Sybodies expressed in Pichia were bound with pigments
Next, we set to purify the sybodies using immobilized metal affinity chromatography (IMAC). For efficient Ni-NTA binding (Fig. 2A), the medium was dialyzed against 1 × PBS buffer before incubated with Ni-NTA beads. For large-scale purification, dialysis becomes impractical. Therefore, alternatively, the medium was treated with 24.2 %(w/v) ammonium sulfate to precipitate sybodies. The re-dissolved sybody could only bind Ni-NTA beads weakly. Thus, an affinity purification step using Protein A was added. Sybodies eluted from the Protein A beads could efficiently bind to Ni-NTA (Fig. 2B). On SDS-PAGE, sybody purified in this manner had an estimated purity of >90%. However, the protein solution had a strong yellow color (Fig. 2C) even after the ammonium sulfate precipitation and affinity purification steps. In addition, the color could not be removed by anion exchange chromatography, or by washing with high salt (1 M NaCl) or metal ions (1 mM Ca2+ or 5 mM Mg2+) on Ni-NTA column. The spectrophotometric analysis revealed a broad peak in the visible wavelength with λmax near 400 nm in addition to the protein peak at 280 nm (Fig. 2D). The behavior of the pigment, including its stickiness to protein during chromatography and ammonium sulfate precipitation, and the color, is consistent with what has been previously described in the literature (Li et al. 2018; Belew et al. 2008; Moore et al. 2010; Steglich et al. 2020; Azadi et al. 2018). A decade ago, the van der Walle group (Moore et al. 2010) identified the pigment as benzoylated Glu1-2Xyl-N-Ac (Fig. 2E). This compound contains four benzoyl groups which, together with the greasy side of the disaccharide, could form hydrophobic interactions with proteins. In addition, the compound is rich in carbonyl groups which accumulatively endow the molecule with the ability to attract positively-charged residues or surfaces. Finally, the abundant hydroxyl and ether groups can interact with proteins via hydrogen bonds.
3.3 A simple wash step removed the pigment from sybodies
Next, we sought simple methods to remove the pigment. It has been reported in the literature that active carbon can effectively absorb the pigment without significant loss of protein in the case of human growth hormone (Azadi et al. 2018). When tested for the sybodies, however, we found that the color was not completely removed even in the presence of 5%(w/v) active carbon. Rather, approximately 90% of the sybodies were lost after the treatment (Fig. 3A).
Cation exchange and hydrophobic interaction chromatography (Moore et al. 2010; Azadi et al. 2018) have been successfully used in the literature to remove the pigment. Because the sybodies have calculated isoelectric points near pH 5.0 (MR3-MR3-ABD, 5.24; MR17m-MR17m-ABD, 5.03; Sb44-Sb92-ABD, 5.63), cation exchange was not considered, as they would be overall negatively charged under our purification conditions (pH 8.0). Rather, we hypothesized that the binding between the pigment and sybodies may be disrupted competitively by zwitterionic detergents which bear both hydrophobicity and charge. Specifically, the hydrocarbon portion of detergents would compete with the benzoyl moiety of the pigment while the charged head group would disrupt hydrogen bonding between the carbonyl or the hydroxyl of the pigment and proteins. Two zwitterionic detergents, N,N-dimethyl-N-dodecylglycine betaine (Empigen), and lauryldimethylamine N-oxide (LDAO), and the non-ionic detergent Triton X-100 (Fig. 3B) were tested.
Triton X-100 had no effect on removing the pigment. Empigen was modestly effective. Remarkably, LDAO wash resulted in a colorless protein solution, as viewed by the naked eye (Fig. 3C) or by spectrophotometry analysis (Fig. 3D). Thus, the LDAO wash resulted in no detectable absorbance in the region between 350 and 500 nm. Further, by contrast to the active carbon method (Fig. 3A), the LDAO wash did not cause noticeable loss of sybodies (Fig. 3E).
3.4 The wash procedure did not affect the sybody’s binding property
We therefore performed large-scale purification by adding an LDAO wash step on Ni-NTA column. After the de-coloring step, the nanobodies were washed extensively using 30 column volume of LDAO-free buffer to minimize LDAO level. We would note that the residual level of LDAO in the final product was not quantified.
The binding characteristics between the sybody MR3-MR3-ABD and SARS-CoV-2 S RBD were tested using the sybody washed LDAO and compared with that from E. coli which was purified by IMAC without LDAO wash. As shown in Fig. 4, they showed almost identical binding curves. As we reported separately (Li et al. 2020), the sybody purified by LDAO wash could neutralize SARS-CoV-2 pseudovirus and protected mice from live virus challenge without showing noticeable toxicity.
3.5 A recommended flowchart for the purification of nanobodies in Pichia
Based on the results, we propose a flowchart for purification of nanobodies as in Fig. 5.
4 Discussion
Pichia pastoris is a robust microorganism for production of recombinant protein at an industrial scale owing to the simplicity and cost-effectiveness in its genetic manipulation and culturing. A well-documented issue, however, is the co-purification of a yellow pigment that is difficult and costly to remove. In this work, we developed a simple, convenient, high-yield, and cost-efficient method for removing the pigment from a SARS-CoV-2-neutralizing nanobody by introducing a washing step with a zwitterionic detergent.
Compared with previous cation exchange and hydrophobic interaction chromatography methods, the detergent wash method has several advantages. First, it can be easily incorporated into affinity purification procedures since LDAO does not interfere with affinity interactions. Second, the materials introduced (LDAO) during the detergent wash can be immediately and easily removed on the same affinity column. This is by sharp contrast with the other two methods where salts are inevitably introduced during the wash, and the salts need to be removed by a separate step such as gel filtration or dialysis. Third, the detergent wash can be done on a gravity column, avoiding the use of automated equipment. This can be especially useful in laboratories where resources are limited or not easily implemented. Our work therefore provided a promising strategy to produce SARS-CoV-2 neutralizing nanobodies in large quantities. Although the general applicability of the method to other heterologous secretory proteins remains to be investigated, the non-specificity nature of the pigment-protein interaction would certainly encourage the test of this method to other proteins. In long term, the results may inspire novel application of the current or improved format(s) to the production of other bioactive proteins in both academy and industry research fields.
5 Conclusions
We have developed a technique to eliminate an acidic, yellow pigment associated with secreted proteins in Pichia. The central aspect of this method involves washing the protein on a matrix using the zwitterionic detergent LADO. As illustrated by the purification of a SARS-CoV-2 neutralizing nanobody, proteins obtained through this protocol retain their biological activity. This method holds potential for purifying pharmaceutically relevant proteins from Pichia, catering to both research and industrial applications.
Availability of data and materials
Data are contained within the article.
References
Ahmad M, Hirz M, Pichler H, Schwab H. Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol. 2014;98:5301–17.
Arruda A, et al. A constitutive expression system for Pichia pastoris based on the PGK1 promoter. Biotechnol Lett. 2016;38:509–17.
Azadi S, et al. Bioprocess and downstream optimization of recombinant human growth hormone in Pichia pastoris. Res Pharm Sci. 2018;13:222–38.
Belew M, et al. Purification of Recombinant Human Serum Albumin (rHSA) Produced by Genetically Modified Pichia Pastoris. Sep Sci Technol. 2008;43:3134–53.
Bos IG, et al. Recombinant human C1-inhibitor produced in Pichia pastoris has the same inhibitory capacity as plasma C1-inhibitor. Biochim Biophys Acta. 2003;1648:75–83.
Byrne B. Pichia pastoris as an expression host for membrane protein structural biology. Curr Opin Struct Biol. 2015;32:9–17.
Cai H, et al. An improved fluorescent tag and its nanobodies for membrane protein expression, stability assay, and purification. Commun Biol. 2020;3:753.
Cai H, Yao H, Li T, Tang Y, Li D. High-level heterologous expression of the human transmembrane sterol Δ8, Δ7-isomerase in Pichia pastoris. Protein Expr Purif. 2019;164:105463.
Cayetano-Cruz M, et al. High level expression of a recombinant xylanase by Pichia pastoris cultured in a bioreactor with methanol as the sole carbon source: Purification and biochemical characterization of the enzyme. Biochem Eng J. 2016;112:161–9.
Cereghino JL, Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev. 2000;24:45–66.
Chang C-H, Hsiung H-A, Hong K-L, Huang C-T. Enhancing the efficiency of the Pichia pastoris AOX1 promoter via the synthetic positive feedback circuit of transcription factor Mxr1. BMC Biotechnol. 2018;18:81.
Cregg JM, et al. High-Level Expression and Efficient Assembly of Hepatitis B Surface Antigen in the Methylotrophic Yeast Pichia Pastoris. Bio/Technology. 1987;5:479–85.
Farnós O, et al. High-level expression and immunogenic properties of the recombinant rabbit hemorrhagic disease virus VP60 capsid protein obtained in Pichia pastoris. J Biotechnol. 2005;117:215–24.
Files D, Ogawa M, Scaman CH, Baldwin SA. A Pichia pastoris fermentation process for producing high-levels of recombinant human cystatin-C. Enzyme Microb Technol. 2001;29:335–40.
Guerrero-Olazarán M, Rodríguez-Blanco L, Carreon-Treviño JG, Gallegos-López JA, Viader-Salvadó JM. Expression of a Bacillus Phytase C Gene in Pichia pastoris and Properties of the Recombinant Enzyme. Appl Environ Microbiol. 2010;76:5601–8.
Juturu V, Wu JC. Heterologous Protein Expression in Pichia pastoris: Latest Research Progress and Applications. ChemBioChem. 2018;19:7–21.
Karim KMR, et al. Characterization and expression in Pichia pastoris of a raw starch degrading glucoamylase (GA2) derived from Aspergillus flavus NSH9. Protein Expr Purif. 2019;164: 105462.
Katla S, et al. High level extracellular production of recombinant human interferon alpha 2b in glycoengineered Pichia pastoris: culture medium optimization, high cell density cultivation and biological characterization. J Appl Microbiol. 2019;126:1438–53.
Kim S-I, Wu Y, Kim K-L, Kim G-J, Shin H-J. Improved cell disruption of Pichia pastoris utilizing aminopropyl magnesium phyllosilicate (AMP) clay. World J Microbiol Biotechnol. 2013;29:1129–32.
Krainer FW, et al. Recombinant protein expression in Pichia pastoris strains with an engineered methanol utilization pathway. Microbial Cell Factories. 2012;11:22.
Li S, et al. A novel purification procedure for recombinant human serum albumin expressed in Pichia pastoris. Protein Expr Purif. 2018;149:37–42.
Li T, et al. A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection. Nat Commun. 2020;12:4635.
Li T, et al. Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody. EMBO Mol Med. 2021;13:e14544.
Li T, et al. Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants. Front Microbiol. 2022;13:875840.
Li T, et al. Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2. Int J Biol Macromol. 2022;209:1379–88.
Lin-Cereghino GP, et al. The effect of α-mating factor secretion signal mutations on recombinant protein expression in Pichia pastoris. Gene. 2013;519:311–7.
Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM. Heterologous protein production using the Pichia pastoris expression system. Yeast. 2005;22:249–70.
Mallem M, et al. Maximizing recombinant human serum albumin production in a Muts Pichia pastoris strain. Biotechnol Prog. 2014;30:1488–96.
Marx H, Mecklenbräuker A, Gasser B, Sauer M, Mattanovich D. Directed gene copy number amplification in Pichia pastoris by vector integration into the ribosomal DNA locus. FEMS Yeast Res. 2009;9:1260–70.
Matthews CB, Kuo A, Love KR, Love JC. Development of a general defined medium for Pichia pastoris. Biotechnol Bioeng. 2018;115:103–13.
Minning S, Schmidt-Dannert C, Schmid RD. Functional expression of Rhizopus oryzae lipase in Pichia pastoris: high-level production and some properties. J Biotechnol. 1998;66:147–56.
Moore BD, Deere J, Edrada-Ebel R, Ingram A, van der Walle CF. Isolation of recombinant proteins from culture broth by co-precipitation with an amino acid carrier to form stable dry powders. Biotechnol Bioeng. 2010;106:764–73.
Nagai N, et al. Recombinant human microplasmin: production and potential therapeutic properties. J Thromb Haemost. 2003;1:307–13.
Nokelainen M, et al. High-level production of human type I collagen in the yeast Pichia pastoris. Yeast. 2001;18:797–806.
Polez S, et al. A Simplified and Efficient Process for Insulin Production in Pichia pastoris. PLoS One. 2016;11:e0167207.
Radulescu A, Zorko NA, Yu X, Besner GE. Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis. Pediatr Res. 2009;65:437–42.
Razdan S, Wang J-C, Barua S. PolyBall: A new adsorbent for the efficient removal of endotoxin from biopharmaceuticals. Sci Rep. 2019;9:8867.
Romanos M. Advances in the use of Pichia pastoris for high-level gene expression. Curr Opin Biotechnol. 1995;6:527–33.
Rosenfeld SA, et al. Production and purification of recombinant hirudin expressed in the methylotrophic yeast Pichia pastoris. Protein Expr Purif. 1996;8:476–82.
Shu M, et al. Expression, activation and characterization of porcine trypsin in Pichia pastoris GS115. Protein Expr Purif. 2015;114:149–55.
Shukla R, et al. Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo. Front Microbiol. 2017;8:2644.
Spadiut O, Capone S, Krainer F, Glieder A, Herwig C. Microbials for the production of monoclonal antibodies and antibody fragments. Trends Biotechnol. 2014;32:54–60.
Sreekrishna K, et al. High level expression of heterologous proteins in methylotrophic yeast Pichia pastoris. J Basic Microbiol. 1988;28:265–78.
Steglich M, et al. Expression, purification and initial characterization of human serum albumin domain I and its cysteine 34. PLoS One. 2020;15:e0240580.
Van Roy M, et al. The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis. Arthritis Res Ther. 2015;17:135.
Wood MJ, Komives EA. Production of large quantities of isotopically labeled protein in Pichia pastoris by fermentation. J Biomol NMR. 1999;13:149–59.
Xiong AS, et al. High level expression of a recombinant acid phytase gene in Pichia pastoris. J Appl Microbiol. 2005;98:418–28.
Xu N, et al. Identification and characterization of novel promoters for recombinant protein production in yeast Pichia pastoris. Yeast. 2018;35:379–85.
Yao H, et al. A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2. PLoS Pathog. 2020;17:e1009328.
Yu KM, et al. Efficient expression and isolation of recombinant human interleukin-11 (rhIL-11) in Pichia pastoris. Protein Expr Purif. 2018;146:69–77.
Zhao W, et al. High Level Expression of an Acid-Stable Phytase from Citrobacter freundii in Pichia pastoris. Appl Biochem Biotechnol. 2010;162:2157–65.
Higgins DR. Overview of protein expression in Pichia pastoris. Curr Protoc Protein Sci Chapter 5, Unit5.7 (2001).
Acknowledgments
The authors thank the staff members of the Large-scale Protein Preparation System at the National Facility for Protein Science in Shanghai for equipment maintenance and management. This work has been supported by the National Natural Science Foundation of China (82151215, D.L., 32201000, T.L.), the Strategic Priority Research Program of CAS (XDB37020204), Science and Technology Commission of Shanghai Municipality (22ZR1468300, D.Li), and the Heye Scholarship Program (T.L.).
Author information
Authors and Affiliations
Contributions
T.L., H.C., Y.L., and H.Y. performed experiment, analyzed results and assisted with manuscript preparation. D.L. designed experiments and wrote the manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Li, T., Cai, H., Lai, Y. et al. A simple and effective method to remove pigments from heterologous secretory proteins expressed in Pichia pastoris. Adv. Biotechnol. 2, 5 (2024). https://doi.org/10.1007/s44307-024-00013-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s44307-024-00013-z